17.11.2010EPFL Life Science Symposium 2011 - LausanneYou are hereEventsBioAlps eventsEPFL Life Science Symposium 2011 - Lausanne
The EPFL Life Science Symposium 2011 will be held at EPFL on
Sept. 7-10, 2011.
Please save the date for this very interesting symposium which will be placed under the scientific and organizational responsibility of the ISREC (the Swiss Institute for Experimental Cancer Research at the School of Life Sciences / EPFL).
"Hallmarks and horizons of cancer": 07 September (17:00) to 10 September (23:00), 2011
The ISREC Symposia take place biannually as part of the Life Sciences Symposium series of the School of Life Sciences at the Swiss Federal Institute of Technology Lausanne (EPFL- Ecole Polytechnique Fédérale de Lausanne). The theme of the 2011 symposium is centered upon an organizing principle – the hallmarks of cancer – that has proved instructive for appreciating underlying commonalities to the vast number of disparate and complex human cancers. The premise, laid out by Hanahan and Weinberg in 2000, is that most lethal tumors acquire, by different ways and means, a common set of six capabilities that are collectively necessary for tumors to grow and disseminate. The realization that such distinctive and quasi-independent functional capabilities are generally important for most tumors is beginning to influence cancer therapeutics, by presenting the concept of dual targeting with drugs aimed at multiple hallmark capabilities, seeking to improve the extent and duration of clinical benefit above and beyond what is possible with a single drug.
Additionally, the scope of the hallmarks concept is expanding to include emerging hallmarks such as the roles of inflammation in cancer, and of altered metabolism to fuel tumor growth.
The conference will have lectures from renowned cancer scientists on the latest results and their implications, and about horizons of cancer research that have promise to lead to new mechanism-based therapies for human cancer.
For your information, 3 awards will be given during this conference:
-CHF 50'000 Debiopharm Life Science award
-2 X CHF 25'000 for Young Researchers from Swiss Research Institutions
More information will be provided very soon.